Hospital Gregorio Marañón

Madrid 28009

3 studies enrolling now · 16 studies all time

What they study most

Acute Myocardial Infarction (AMI), Acute Respiratory Failure, COVID, Cardiovascular Disease, Cardiovascular Risk, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Heart Failure, Myeloproliferative Neoplasm, Obesity, Overweight, Pancreatic Cancer

Studies at this site

• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Running, not enrolling
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight — Running, not enrolling
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment — Enrolling by invitation
• A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) — Running, not enrolling
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
• A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes — Completed
• Myeloproliferative Neoplasms (MPN) and COVID-19 — Completed
• Transthyretin Amyloidosis Outcome Survey (THAOS) — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study — Completed
• PALISADE Follow-on Study (ARC004) — Completed
• Third International Study on Mechanical Ventilation — Completed